SELLAS Life Sciences Group, Inc. SLS
- tambiciclib — Acute Myeloid Leukemia Phase 2
- tambiciclib — Peripheral T-Cell Lymphoma
- tambiciclib — Pediatric Acute Lymphoblastic Leukemia Preclinical
CDK9 (1 companies · 3 programs)
Companies with an active program directed at CDK9.